STARSIL® Hemostat
ULTRA-HYDROPHILIC ABSORBABLE POLYSACCHARIDE TECHNOLOGY
Introduction to STARSIL Hemostat
STARSIL® Hemostat by Hemostat Medical represents the next generation of surgical hemostatic agents designed to provide rapid and effective bleeding control during complex medical procedures.
Engineered with cutting-edge biotechnology, this product ensures immediate hemostasis by forming a stable barrier that supports natural clotting mechanisms. The innovative powder-based formulation allows for precise application even in challenging surgical environments.
Unlike traditional hemostatic materials, STARSIL ® Hemostat is entirely biocompatible and absorbable, minimizing the risk of adverse tissue reactions. Its composition enables optimal fluid absorption, which accelerates coagulation without the use of animal-derived substances or human plasma.
This makes it a safe choice for both surgeons and patients. The product’s versatility allows it to be used in open, laparoscopic, and endoscopic procedures, where precision and sterility are essential. Surgeons worldwide value Hemostat Medical’s commitment to innovation, ensuring consistent results and improved patient outcomes.
By combining advanced material science with clinical expertise, STARSIL ® Hemostat sets a new standard in the field of surgical hemostasis.
Composition and Mechanism of Action
The effectiveness of STARSIL ® Hemostat lies in its unique polysaccharide-based structure, designed to interact naturally with blood components to accelerate clot formation.
Upon contact with blood, the powder rapidly absorbs plasma, concentrating platelets and coagulation factors at the bleeding site. This results in an immediate physical barrier that supports the body’s natural clotting process.
The biodegradable formulation of STARSIL ® Hemostat ensures that it is completely absorbed by the body within a few days, leaving no residue or foreign material. It contains no animal proteins, synthetic additives, or human blood components, significantly reducing the risk of infection and immunological reactions.
Its neutral pH value and non-toxic nature make it suitable for a wide range of surgical applications. Laboratory and clinical studies have demonstrated that STARSIL ® Hemostat can effectively stop bleeding faster than many conventional agents.
This reliability makes it a preferred solution in various fields of surgery, including general, orthopedic, cardiac, and neurosurgery. In addition, its dry, free-flowing powder form allows for easy application even in hard-to-reach anatomical areas.
Clinical Applications and Surgical Benefits
STARSIL ® Hemostat is widely used across numerous surgical specialties, including cardiac surgery, neurosurgery, orthopedics, gynecology, and transplantation surgery.
Its fast action and broad applicability make it a vital tool for surgeons aiming to minimize blood loss and operative time. In minimally invasive surgery, STARSIL ® Hemostat demonstrates particular advantages due to its powder delivery system, which ensures uniform coverage of bleeding surfaces without causing tissue damage.
Surgeons appreciate its simplicity—no preparation time, no mixing, and immediate readiness for use. The applicator systems, such as UNITIP ENDO, allow precise placement even in endoscopic procedures.
Clinical results confirm that STARSIL ® Hemostat not only improves visibility within the surgical field but also reduces the need for electrocautery or sutures, leading to less postoperative pain and faster recovery for patients. Moreover, the product’s versatility across both dry and moist environments makes it reliable in diverse surgical conditions.
Its proven biocompatibility supports faster wound healing and lower postoperative complications, underscoring its position as a premium hemostatic solution for professional healthcare environments.
Quality and Innovation by Hemostat Medical
Hemostat Medical GmbH, headquartered in Germany, is a leading developer and manufacturer of advanced hemostatic technologies for surgical applications.
The company’s commitment to quality and innovation is evident in every step of the product development process—from material research to clinical validation. STARSIL ® Hemostat is a flagship product that embodies the company’s mission to deliver safe, effective, and scientifically proven hemostatic agents to the global medical community.
Each batch undergoes rigorous quality control testing in compliance with ISO and CE certification standards. The company’s continuous investment in research and partnerships with international hospitals ensures that products like STARSIL Hemostat meet the highest clinical expectations.
Hemostat Medical combines German engineering precision with medical expertise to create devices that simplify surgical procedures and enhance patient outcomes.
Through its dedication to innovation and education, Hemostat Medical supports surgeons worldwide in achieving reliable results and setting new standards in modern surgical hemostasis.
